Can Blood Tests Detect Cancer?
Blood tests can detect cancer — but not in the way most people expect. A single blood test cannot definitively diagnose cancer on its own. However, specific blood tests identify markers that strongly indicate cancer’s presence, track its progression, and monitor treatment response. Understanding which blood tests detect cancer markers, what their results mean, and what their limitations are helps you make informed decisions about your health. Moreover, knowing when to request these tests could save your life — because cancer caught early is almost always more treatable. This guide covers every important cancer-related blood test, what each one detects, and when to get tested at Prakash Pathology, Varanasi. How Blood Tests Detect Cancer — The Science Behind It Cancer cells behave differently from normal cells. They divide uncontrollably, consume resources aggressively, and release specific proteins, enzymes, and genetic fragments into the bloodstream. Moreover, cancer disrupts normal organ function — producing measurable changes in routine blood parameters. Blood tests detect cancer through two primary mechanisms. First, tumour marker tests identify specific proteins that cancer cells produce in elevated quantities. Second, routine blood tests — like the CBC and LFT — detect abnormal patterns that indicate cancer’s indirect effects on the body. Why No Single Test Confirms Cancer Alone A positive tumour marker does not automatically confirm cancer. Moreover, some non-cancerous conditions also elevate tumour markers. Consequently, doctors always combine blood test results with imaging, biopsy, and clinical examination before reaching a cancer diagnosis. Furthermore, a normal tumour marker result does not completely rule out cancer — because not all cancers elevate every marker consistently. This is why understanding both the power and the limitations of these tests is essential. Blood Tests That Help Detect Cancer 1. Complete Blood Count (CBC) — The First Indicator The CBC is the most commonly ordered blood test in medicine. It measures red blood cells, white blood cells, and platelets. Moreover, several patterns in a CBC reading strongly suggest certain cancers — even before any specific tumour marker test is ordered. What the CBC reveals about cancer: When CBC Results Prompt Further Testing A single abnormal CBC does not diagnose cancer. However, persistently abnormal results — particularly a rising WBC count without infection, or a falling platelet count without obvious cause — always prompt a peripheral blood smear and specialist referral. Furthermore, catching these patterns early through routine annual CBC testing is one of the most accessible forms of cancer screening available. 2. Tumour Markers — Specific Cancer Indicators Tumour markers are proteins, hormones, or other substances that cancer cells produce in elevated quantities. Blood tests detect cancer through tumour markers most specifically — making these the most targeted cancer screening tools available. Tumour Marker Cancer It Indicates Normal Range PSA (Prostate Specific Antigen) Prostate cancer Below 4 ng/mL CA 125 Ovarian cancer Below 35 U/mL CA 19-9 Pancreatic, bile duct cancer Below 37 U/mL CA 15-3 Breast cancer Below 30 U/mL CEA (Carcinoembryonic Antigen) Colorectal, lung, breast cancer Below 2.5 ng/mL (non-smokers) AFP (Alpha-Fetoprotein) Liver cancer, testicular cancer Below 10 ng/mL Beta-HCG Testicular cancer, choriocarcinoma Below 5 mIU/mL LDH (Lactate Dehydrogenase) Lymphoma, leukaemia, testicular cancer 140 – 280 U/L How to Interpret Tumour Marker Results Elevated tumour markers are significant — but not conclusive alone. Moreover, the degree of elevation matters considerably. A mildly elevated PSA may indicate prostate enlargement rather than cancer. However, a dramatically elevated AFP strongly suggests liver cancer and warrants urgent investigation. Furthermore, tumour markers are most valuable when tracked over time. A rising marker trend is often more informative than a single high reading. Consequently, doctors order repeat tests at intervals to assess whether levels are stable, falling, or rising progressively. 3. Liver Function Test (LFT) — Detecting Liver Cancer Signals The liver is one of the most common sites of both primary cancer and metastatic spread from other cancers. An LFT measures several liver enzymes and proteins. Moreover, specific abnormal patterns in LFT results raise strong suspicion of liver involvement. LFT patterns that suggest cancer: Additionally, doctors always order an AFP test alongside an LFT when liver cancer is suspected — because elevated AFP combined with abnormal LFT findings significantly strengthens the diagnostic picture. 4. PSA Test — Prostate Cancer Screening The PSA test is the most widely used cancer screening blood test for men above 50. Prostate cells — both normal and cancerous — produce PSA. However, prostate cancer cells produce it in far greater quantities. Understanding PSA results: Moreover, the PSA test is not perfect. Some prostate cancers do not elevate PSA significantly. Consequently, doctors combine PSA results with digital rectal examination and imaging before confirming any diagnosis. 5. CA 125 — Ovarian Cancer Screening CA 125 is a protein produced by ovarian cancer cells. It is the primary blood marker for ovarian cancer monitoring. Moreover, it is particularly useful for tracking treatment response in women already diagnosed with ovarian cancer. Important limitations of CA 125: CA 125 is not a perfect screening tool for women without symptoms. Several non-cancerous conditions — including endometriosis, fibroids, pelvic inflammatory disease, and even pregnancy — elevate CA 125 levels. Consequently, an elevated CA 125 in a woman with pelvic pain or bloating prompts further imaging — it does not confirm cancer alone. However, a significantly elevated CA 125 — particularly above 200 U/mL — in a postmenopausal woman with pelvic symptoms warrants urgent specialist evaluation without delay. 6. CEA — Colorectal Cancer Monitoring CEA — Carcinoembryonic Antigen — is a protein elevated in several cancers, particularly colorectal cancer. Moreover, CEA is most valuable for monitoring colorectal cancer after treatment — tracking whether cancer has recurred following surgery or chemotherapy. What elevated CEA suggests: A CEA above 5 ng/mL in a non-smoker with digestive symptoms — particularly changes in bowel habits, blood in stool, or unexplained weight loss — warrants a colonoscopy without delay. Furthermore, a rising CEA trend in a patient previously treated for colorectal cancer almost always indicates recurrence — prompting immediate imaging and specialist review. 7.
Can Blood Tests Detect Cancer? Read More »









